Software to predict the right dose for vancomycin in a clinical environment-A commentary on: Personalised dosing of vancomycin: A prospective and retrospective comparative quasi-experimental study by Luqman Vali et al
Br J Clin Pharmacol
.
2021 Sep;87(9):3481-3482.
doi: 10.1111/bcp.14765.
Epub 2021 Feb 27.
Authors
Jacob A Dijkstra
1
,
Agnes I Veldkamp
1
,
Elske Sieswerda
2
,
Michiel van Agtmael
3
Affiliations
1
Department of Pharmacy and Clinical Pharmacology, Amsterdam University Medical Center, Amsterdam, The Netherlands.
2
Department of Medical Microbiology and Infection Control, Amsterdam University Medical Center, Amsterdam, The Netherlands.
3
Department of Internal Medicine, Amsterdam University Medical Center, Amsterdam, The Netherlands.
PMID:
33638868
PMCID:
PMC8451928
DOI:
10.1111/bcp.14765
No abstract available
Publication types
Comment
MeSH terms
Anti-Bacterial Agents* / adverse effects
Humans
Prospective Studies
Retrospective Studies
Software
Vancomycin* / adverse effects
Substances
Anti-Bacterial Agents
Vancomycin